Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Arvinas and Pfizer enter up to $2.4bn deal to develop breast cancer drug

pharmaceutical-technologyJuly 26, 2021

Tag: Arvinas , Pfizer , Breast Cancer , ARV-471

PharmaSources Customer Service